Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/120856
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMuñoz, Nubia-
dc.contributor.authorHernandez-Suarez, G.-
dc.contributor.authorMéndez, F.-
dc.contributor.authorMolano, Monica-
dc.contributor.authorPosso, H.-
dc.contributor.authorMoreno Aguado, Víctor-
dc.contributor.authorMurillo, R.-
dc.contributor.authorRonderos, M.-
dc.contributor.authorMeijer, Chris J. L. M.-
dc.contributor.authorMuñoz, Á.-
dc.contributor.authorINC HPV Study Group-
dc.date.accessioned2018-03-19T10:25:24Z-
dc.date.available2018-03-19T10:25:24Z-
dc.date.issued2009-04-07-
dc.identifier.issn0007-0920-
dc.identifier.urihttp://hdl.handle.net/2445/120856-
dc.description.abstractLittle is known about the dynamics of human papillomavirus (HPV) infection and subsequent development of high-grade cervical intraepithelial neoplasia (CIN2/3), particularly in women >30 years of age. This information is needed to assess the impact of HPV vaccines and consider new screening strategies. A cohort of 1728 women 15-85 years old with normal cytology at baseline was followed every 6 months for an average of 9 years. Women with squamous intraepithelial lesions were referred for biopsy and treatment. The Kaplan-Meier method was used to estimate the median duration of infection and Cox regression analysis was undertaken to assess determinants of clearance and risk of CIN2/3 associated with HPV persistence. No difference in the likelihood of clearance was observed by HPV type or woman's age, with the exception of lower clearance for HPV16 infection in women under 30 years of age. Viral load was inversely associated with clearance. In conclusion, viral load is the main determinant of persistence, and persistence of HPV16 infections carry a higher risk of CIN2/3.-
dc.format.extent7 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherCancer Research UK-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/sj.bjc.6604972-
dc.relation.ispartofBritish Journal of Cancer, 2009, vol. 100, num. 7, p. 1184-1190-
dc.relation.urihttps://doi.org/10.1038/sj.bjc.6604972-
dc.rightscc-by-nc-sa (c) Muñoz, N. et al., 2009-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/es-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationPapil·lomavirus-
dc.subject.classificationVacuna del papil·lomavirus-
dc.subject.classificationColl uterí-
dc.subject.classificationTumors-
dc.subject.classificationFactors de risc en les malalties-
dc.subject.classificationDones-
dc.subject.classificationColòmbia-
dc.subject.otherPapillomaviruses-
dc.subject.otherPapillomavirus vaccines-
dc.subject.otherCervix uteri-
dc.subject.otherTumors-
dc.subject.otherRisk factors in diseases-
dc.subject.otherWomen-
dc.subject.otherColombia-
dc.titlePersistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec575079-
dc.date.updated2018-03-19T10:25:24Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid19293802-
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
575079.pdf136.73 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons